Among patients with high-risk prostate cancer and no evidence of metastatic disease on conventional imaging, ...

Morgan Stanley (NYSE:MS) analysts have upgraded Vir Biotechnology (NASDAQ:VIR) to an "overweight" rating, shifting from "equal-weight," and have also increased their price target to $20 from $10. The ...

Researchers at Children's Hospital of Philadelphia (CHOP) and the Perelman School of Medicine at the University of ...

Researchers conducted a post hoc, retrospective, cross-sectional analysis of 182 patients with recurrent prostate cancer ...

Microbix has been a leading producer of purified and inactivated Antigens from native (natural) bacterial and viral organisms for more than three decades. It supplies these critical biological ...

You don't need a prescription to purchase a test that will tell you whether you're sick with COVID or the flu.

ARKANSAS, USA — UAMS has received a five-year, $2.9 million research grant from the National Institutes of Health based on a ...

Prostate cancer imaging developed by university researchers has shown “extremely encouraging” results in its first clinical ...

When a pregnant woman had her blood sampled back in 1972, doctors discovered it was mysteriously missing a surface molecule ...

Scientists have discovered the secret behind a very rare blood type called AnWj. They figured out which gene is responsible ...

Russell W. Jenkins, MD, PhD, a physician investigator in the Krantz Family Center for Cancer Research at the Mass General Cancer Center and an assistant professor of Medicine at Harvard Medical School ...